{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:50:02Z","timestamp":1791949802865,"version":"4.3.4"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,3,4]],"date-time":"2018-03-04T00:00:00Z","timestamp":1520121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK098566"],"award-info":[{"award-number":["DK098566"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Mice overexpressing high molecular weight FGF2 isoforms (HMWTg) in osteoblast lineage phenocopy human X-linked hypophosphatemic rickets (XLH) and a Hyp murine model of XLH demonstrating increased FGF23\/FGF receptor signaling and hypophosphatemic rickets\/osteomalacia. Because HMWFGF2 was upregulated in bones of Hyp mice and abnormal FGF23 signaling is important in XLH, HMWTg mice were used to examine the effect of the FGF23 neutralizing antibody (FGF23Ab). Eight-week-old female Vector control mice and HMWTg mice were treated with FGF23Ab or control IgG. A single injection of FGF23Ab rescued abnormal hypophosphatemia in HMWTg. The decreased type II sodium-dependent phosphate co-transporter (Npt2a) was rescued by FGF23Ab treatment. Inappropriately low serum 1,25(OH)2D in HMWTg mice was normalized by FGF23Ab treatment, which is accompanied by increased anabolic vitamin D hydroxylase Cyp27b1 and decreased catabolic vitamin D hydroxylase Cyp24 mRNA in kidney. Long-term treatment with FGF23Ab normalized femur length and significantly increased vertebrae BMD and BMC, and femur BMC in HMWTg mice compared to IgG-treated HMWTg mice. Micro\u2013computed tomography (\u03bcCT) revealed increased cortical porosity and decreased cortical apparent density in the HMWTg-IgG group compared with the Vector-IgG group; however, FGF23Ab treatment rescued defective cortical mineralization, decreased porosity, and increased apparent density in HMWTg mice. Bone histomorphometry analysis showed FGF23Ab treatment decreased osteoid volume, increased intra-label thickness, mineralization apposition rate, and bone formation rate in HMWTg mice. FGF23Ab improved disorganized double labeling in femurs from HMWTg mice. Quantitative real-time PCR analysis of tibia shafts showed FGF23Ab treatment normalized the osteocalcin (Ocn) mRNA expression in HMWTg mice, but further increased expression of SIBLING protein\u2013related and pyrophosphate-related genes that are important in matrix mineralization, suggesting that HMWFGF2 modulates these genes independent of FGF23. We conclude that FGF23Ab partially rescued hypophosphatemic osteomalacia in HMWTg. However, long-term treatment with FGF23Ab further increased SIBLING protein\u2013related genes and pyrophosphate-related genes in bone that could contribute to incomplete rescue of the mineralization defect. \u00a9 2018 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.3417","type":"journal-article","created":{"date-parts":[[2018,3,4]],"date-time":"2018-03-04T20:02:36Z","timestamp":1520193756000},"page":"1347-1361","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice"],"prefix":"10.1093","volume":"33","author":[{"given":"Liping","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of MedicineUniversity of Connecticut School of MedicineUCONN HealthFarmingtonCTUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Homer-Bouthiette","sequence":"additional","affiliation":[{"name":"Department of MedicineUniversity of Connecticut School of MedicineUCONN HealthFarmingtonCTUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja M","family":"Hurley","sequence":"additional","affiliation":[{"name":"Department of MedicineUniversity of Connecticut School of MedicineUCONN HealthFarmingtonCTUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,4]]},"reference":[{"issue":"9","key":"2024021014334528100_jbmr3417-bib-0001","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1681\/ASN.2005050573","article-title":"Fibroblast growth factor 23: roles in health and disease","volume":"16","author":"Imel","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2024021014334528100_jbmr3417-bib-0002","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","article-title":"Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"2024021014334528100_jbmr3417-bib-0003","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"2024021014334528100_jbmr3417-bib-0004","first-page":"367","article-title":"The changing face of hypophosphatemic disorders in the FGF-23 era","volume":"10","author":"Lee","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"issue":"4","key":"2024021014334528100_jbmr3417-bib-0005","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021014334528100_jbmr3417-bib-0006","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bonr.2016.05.004","article-title":"Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia","volume":"5","author":"Ruppe","year":"2016","journal-title":"Bone Rep"},{"issue":"4","key":"2024021014334528100_jbmr3417-bib-0007","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jcph.611","article-title":"Population pharmacokinetic and pharmacodynamic analyses from a 4-month intradose escalation and its subsequent 12-month dose titration studies for a human monoclonal anti-FGF23 antibody (KRN23) in adults with X-linked hypophosphatemia","volume":"56","author":"Zhang","year":"2016","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2024021014334528100_jbmr3417-bib-0008","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jcph.570","article-title":"Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia","volume":"56","author":"Zhang","year":"2016","journal-title":"J Clin Pharmacol"},{"issue":"7","key":"2024021014334528100_jbmr3417-bib-0009","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024021014334528100_jbmr3417-bib-0010","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"2024021014334528100_jbmr3417-bib-0011","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/17453679608994678","article-title":"Basic fibroblast growth factor infused at different times during bone graft incorporation. Titanium chamber study in rats","volume":"67","author":"Wang","year":"1996","journal-title":"Acta Orthop Scand"},{"issue":"3","key":"2024021014334528100_jbmr3417-bib-0012","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1210\/endo-124-3-1539","article-title":"Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix","volume":"124","author":"Globus","year":"1989","journal-title":"Endocrinology"},{"key":"2024021014334528100_jbmr3417-bib-0013","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/B978-012098652-1.50149-9","volume-title":"Principles of bone biology","author":"Hurley","year":"2002","edition":"2nd ed"},{"issue":"11","key":"2024021014334528100_jbmr3417-bib-0014","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.86.11.3978","article-title":"Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons","volume":"86","author":"Florkiewicz","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2024021014334528100_jbmr3417-bib-0015","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1091\/mbc.10.5.1429","article-title":"Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals","volume":"10","author":"Arese","year":"1999","journal-title":"Mol Biol Cell"},{"issue":"1","key":"2024021014334528100_jbmr3417-bib-0016","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)01189-3","article-title":"The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism","volume":"468","author":"Delrieu","year":"2000","journal-title":"FEBS Lett"},{"issue":"3-4","key":"2024021014334528100_jbmr3417-bib-0017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0248-4900(03)00033-9","article-title":"Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons","volume":"95","author":"Touriol","year":"2003","journal-title":"Biol Cell"},{"issue":"3","key":"2024021014334528100_jbmr3417-bib-0018","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jcp.21139","article-title":"Chromatin compaction and cell death by high molecular weight FGF-2 depend on its nuclear localization, intracrine ERK activation, and engagement of mitochondria","volume":"213","author":"Ma","year":"2007","journal-title":"J Cell Physiol"},{"issue":"5","key":"2024021014334528100_jbmr3417-bib-0019","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/jcb.21116","article-title":"Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age","volume":"100","author":"Yu","year":"2007","journal-title":"J Cell Biochem"},{"issue":"1","key":"2024021014334528100_jbmr3417-bib-0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jbmr.1721","article-title":"Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23\/FGFR\/MAPK in vitro","volume":"28","author":"Xiao","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024021014334528100_jbmr3417-bib-0021","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1074\/jbc.M804900200","article-title":"Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice","volume":"284","author":"Xiao","year":"2009","journal-title":"J Biol Chem"},{"issue":"4","key":"2024021014334528100_jbmr3417-bib-0022","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1074\/jbc.M109.030577","article-title":"Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO","volume":"285","author":"Xiao","year":"2010","journal-title":"J Biol Chem"},{"issue":"11","key":"2024021014334528100_jbmr3417-bib-0023","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024021014334528100_jbmr3417-bib-0024","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2024021014334528100_jbmr3417-bib-0025","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2024021014334528100_jbmr3417-bib-0026","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2186","article-title":"Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice","volume":"29","author":"Ohata","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024021014334528100_jbmr3417-bib-0027","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/bbrc.2000.4146","article-title":"Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin","volume":"280","author":"Fisher","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2024021014334528100_jbmr3417-bib-0028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"issue":"5","key":"2024021014334528100_jbmr3417-bib-0029","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/154411130401500503","article-title":"The wrickkened pathways of FGF23, MEPE and PHEX","volume":"15","author":"Rowe","year":"2004","journal-title":"Crit Rev Oral Biol Med"},{"issue":"4-5","key":"2024021014334528100_jbmr3417-bib-0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/03008200500237203","article-title":"FGF2 alters expression of the pyrophosphate\/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4)","volume":"46","author":"Hatch","year":"2005","journal-title":"Connect Tissue Res"},{"issue":"2","key":"2024021014334528100_jbmr3417-bib-0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jbmr.5650110207","article-title":"Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells","volume":"11","author":"Solan","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024021014334528100_jbmr3417-bib-0032","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-011-0288-2","article-title":"FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation","volume":"30","author":"Kyono","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2024021014334528100_jbmr3417-bib-0033","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S8756-3282(00)00418-X","article-title":"Expression of type III sodium-dependent phosphate transporters\/retroviral receptors mRNAs during osteoblast differentiation","volume":"28","author":"Nielsen","year":"2001","journal-title":"Bone"},{"issue":"3","key":"2024021014334528100_jbmr3417-bib-0034","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jcp.25458","article-title":"FGF23 Neutralizing antibody ameliorates hypophosphatemia and impaired FGF receptor signaling in kidneys of HMWFGF2 transgenic mice","volume":"232","author":"Du","year":"2017","journal-title":"J Cell Physiol"},{"issue":"5","key":"2024021014334528100_jbmr3417-bib-0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2783","article-title":"1,25-Dihydroxyvitamin D alone improves skeletal growth, microarchitecture, and strength in a murine model of XLH, despite enhanced FGF23 expression","volume":"31","author":"Liu","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2024021014334528100_jbmr3417-bib-0036","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"issue":"2","key":"2024021014334528100_jbmr3417-bib-0037","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","article-title":"Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization","volume":"89","author":"Shalhoub","year":"2011","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"2024021014334528100_jbmr3417-bib-0038","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pgen.1000154","article-title":"Genetic evidence of serum phosphate-independent functions of FGF-23 on bone","volume":"4","author":"Sitara","year":"2008","journal-title":"PLoS Genet"},{"issue":"6","key":"2024021014334528100_jbmr3417-bib-0039","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024021014334528100_jbmr3417-bib-0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/JOE-12-0143","article-title":"The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling","volume":"214","author":"Staines","year":"2012","journal-title":"J Endocrinol"},{"issue":"9","key":"2024021014334528100_jbmr3417-bib-0041","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/154405910808700907","article-title":"Matrix Gla protein inhibition of tooth mineralization","volume":"87","author":"Kaipatur","year":"2008","journal-title":"J Dent Res"},{"issue":"5","key":"2024021014334528100_jbmr3417-bib-0042","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/jcb.22861","article-title":"FGF2 promotes Msx2 stimulated PC-1 expression via Frs2\/MAPK signaling","volume":"111","author":"Li","year":"2010","journal-title":"J Cell Biochem"},{"issue":"4","key":"2024021014334528100_jbmr3417-bib-0043","first-page":"318","article-title":"FGF2 induced expression of the pyrophosphate generating enzyme, PC-1, is mediated by Runx2 and Msx2","volume":"8","author":"Hatch","year":"2008","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"4","key":"2024021014334528100_jbmr3417-bib-0044","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1359\/jbmr.081213","article-title":"FGF2 stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2","volume":"24","author":"Hatch","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024021014334528100_jbmr3417-bib-0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1601-6343.2007.00387.x","article-title":"Potential role of PC-1 expression and pyrophosphate elaboration in the molecular etiology of the FGFR-associated craniosynostosis syndromes","volume":"10","author":"Hatch","year":"2007","journal-title":"Orthod Craniofac Res"},{"issue":"4)","key":"2024021014334528100_jbmr3417-bib-0046","doi-asserted-by":"crossref","first-page":"e1002427","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PLoS Biol"},{"issue":"8","key":"2024021014334528100_jbmr3417-bib-0047","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1359\/jbmr.2000.15.8.1451","article-title":"The effects of bone marrow transplantation on X-linked hypophosphatemic mice","volume":"15","author":"Miyamura","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"33","key":"2024021014334528100_jbmr3417-bib-0048","doi-asserted-by":"crossref","first-page":"20101","DOI":"10.1074\/jbc.A114.609230","article-title":"Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23","volume":"290","author":"Han","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"2024021014334528100_jbmr3417-bib-0049","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jbmr.2606","article-title":"FGF23 Regulates bone mineralization in a 1, 25(OH)2 D3 and Klotho-independent manner","volume":"31","author":"Murali","year":"2016","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3417","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/33\/7\/1347\/56652027\/jbmr3417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/33\/7\/1347\/56652027\/jbmr3417.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:01:28Z","timestamp":1710342088000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/33\/7\/1347-1361\/7605530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,4]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,3,4]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3417","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,1]]},"published":{"date-parts":[[2018,3,4]]},"assertion":[{"value":"2017-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}